Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187200 · ClinicalTrials.gov registry record · Phase 4
Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients
A Phase 4 study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- Phase 4
- Development phase
- 816
- Enrollment target
NCT00187200 is a Phase 4 study that has completed, run by Abbott Medical Devices. The registered enrollment target is 816 participants.
The verdict
NCT00187200, a Phase 4 study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 816 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the benefit of interventricular (V-V) delay optimization in reducing the non-responder rate in patients with cardiac resynchronization defibrillator (CRT-D) devices. The primary endpoint of this study is CRT responder rate. For patients enrolled with new CRT-D systems, patients are considered non-responders if BOTH of the following requirements are fulfilled: * \< 10% improvement in 6-minute hall walk, and * no class improvement or worsening in New York Heart Association (NYHA) scale. For those receiving CRT-D devices as replacements of older CRT-D systems, patients are considered non-responders if BOTH of the following requirements are fulfilled: * \> 1 heart failure (HF) related hospitalization, and * no class improvement or worsening in NYHA scale.
Interventions
- DEVICE Simultaneous VV Pacing
- DEVICE Sequential VV Pacing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 816 participants |
| Start Date | 2005-01 |
| Est. Completion | 2010-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187200
The ClinicalTrials.gov registry entry for NCT00187200 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 816 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Simultaneous VV Pacing is the first listed.
NCT00187200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00187200 about?
NCT00187200 is a clinical study titled "Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients". The purpose of the study is to evaluate the benefit of interventricular (V-V) delay optimization in reducing the non-responder rate in patients with cardiac resynchronization defibrillator (CRT-D) devices. The primary endpoint of this study is CRT responder rate. For patients enrolled with new CRT-...
What is the current status of trial NCT00187200?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 816 participants. The study started on 2005-01. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00187200?
The interventions under investigation include: Simultaneous VV Pacing (DEVICE), Sequential VV Pacing (DEVICE).
Who is sponsoring clinical trial NCT00187200?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.